Viewing Study NCT03128034

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-02-08 @ 3:26 PM
Study NCT ID: NCT03128034
Status: RECRUITING
Last Update Posted: 2025-12-19
First Post: 2017-04-13
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
Sponsor: Fred Hutchinson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia View
None Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome View
None Acute Myeloid Leukemia View
None Chronic Myelomonocytic Leukemia View
None Myelodysplastic Syndrome With Excess Blasts View
None Recurrent Acute Myeloid Leukemia View
None Refractory Acute Lymphoblastic Leukemia View
None Recurrent Acute Lymphoblastic Leukemia View
None Recurrent Mixed Phenotype Acute Leukemia View
None Refractory Acute Myeloid Leukemia View
None Refractory Mixed Phenotype Acute Leukemia View
None Mixed Phenotype Acute Leukemia View
Keywords: